Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study

BACKGROUND: Pneumocystis pneumonia (PCP) is a potentially life-threatening infection. Trimethoprim-sulfamethoxazole (TMP-SMX) is considered as the first regimen for PCP prophylaxis according to several guidelines. The recommended prophylactic dose of TMP-SMX has been determined based on patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamashita, Kanae, Shimomura, Yoshimitsu, Ikesue, Hiroaki, Muroi, Nobuyuki, Yoshimoto, Akihiro, Hashida, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268304/
https://www.ncbi.nlm.nih.gov/pubmed/34238239
http://dx.doi.org/10.1186/s12879-021-06374-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268304/
https://www.ncbi.nlm.nih.gov/pubmed/34238239
http://dx.doi.org/10.1186/s12879-021-06374-3

Ejemplares similares